Cancer News and Research

Latest Cancer News and Research

Mechanical forces generated by T cells influence the destruction of cancer cells

As a part of our immune defenses, cytotoxic T cells – or killer T cells – seek out and destroy cells that are infected or cancerous. This process is essential for the body's defense against diseases.

15 Sep 2022

Court ruling may spur competitive health plans to bring back copays for preventive services

Tom and Mary Jo York are a health-conscious couple, going in for annual physicals and periodic colorectal cancer screening tests. Mary Jo, whose mother and aunts had breast cancer, also gets regular mammography tests.

15 Sep 2022

AI used to identify pancreatic cancer in CT scans

In a recent study published in the journal Radiology, researchers in Taiwan developed a deep learning (DL)–based computer-aided detection (CAD) tool to detect pancreatic cancer on contrast-enhanced abdominal computed tomography (CT) scans.

15 Sep 2022

Defensosomes versus COVID-19

In a recent study published in the journal PLoS Biology, researchers investigated the role of angiotensin-converting enzyme 2 (ACE2)-containing defensive exosomes, or 'defensosomes' against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

14 Sep 2022

Large molecules glom together into dense droplets to create squishy circuits in cells

An emerging field explores how groups of molecules condense together inside cells, the way oil droplets assemble and separate from water in a vinaigrette.

14 Sep 2022

Simple phone-based outreach strategy can help engage low-income smokers to try quitting tobacco

New findings published in Nicotine & Tobacco Research show a simple, but valuable approach can help engage low-income smokers to try quitting tobacco.

14 Sep 2022

Microneedle technology for low-cost, painless, and bloodless tattoos

Instead of sitting in a tattoo chair for hours enduring painful punctures, imagine getting tattooed by a skin patch containing microscopic needles.

14 Sep 2022

STRATAGEM aims to provide new perspectives on multidrug-resistant solid tumors

Achieving a good efficacy of chemotherapy is one of the major challenges still unresolved in oncological patients. The main limitation to the efficacy of chemotherapy is the multidrug-resistant (MDR) phenotype, a multiple cross-resistance towards different anticancer drugs.

14 Sep 2022

Scientists identify two distinct subtypes of obesity

A team led by Van Andel Institute scientists has identified two distinct types of obesity with physiological and molecular differences that may have lifelong consequences for health, disease and response to medication.

14 Sep 2022

California and New York aim to curb diet pill sales to minors

California and New York are on the cusp of going further than the FDA in restricting the sale of non-prescription diet pills to minors as pediatricians and public health advocates try to protect kids from extreme weight-loss gimmicks online.

14 Sep 2022

Study explores the impact of genetic risk variants on overall disease burden and healthy life years

In a new study, researchers explored the genetic risk factors associated with various diseases to understand their impact on healthy life years.

14 Sep 2022

Study estimates the cost-effectiveness of therapeutic alternatives

Giving standard chemotherapy drugs in a specific sequence for some types of metastatic breast cancer can help reduce overall costs and improve the value of care while preserving quality of life, according to a study led by UNC Lineberger Comprehensive Cancer Center and UNC Gillings School of Global Public Health researchers.

14 Sep 2022

Signal transduction via the EGFR pathway likely to be involved in lenvatinib resistance

The multitargeted tyrosine kinase inhibitor (MKI), lenvatinib, is widely used to treat advanced and metastatic thyroid cancer. However, the molecular mechanisms by which thyroid cancer cells become resistant to lenvatinib remain poorly understood. In this study, we demonstrated, for the first time, that activation of the epidermal growth factor receptor (EGFR)-mediated signaling pathway is involved in lenvatinib resistance in thyroid cancer cells.

14 Sep 2022

Risk of dementia reduced 50% by walking 9,800 steps a day

In a recent study published in JAMA Neurology, researchers assessed the association between the number and intensity of steps taken per day and dementia incidence among adults residing in the United Kingdom (UK).

14 Sep 2022

Every step counts to lower cancer and cardiovascular disease risk

In a recent study published in JAMA Internal Medicine, researchers in Australia, Denmark, and the United States pursued evidence of an association between daily walking and its intensity with the risk of cancer and cardiovascular diseases (CVDs) in a cohort of 78,500 individuals aged 40 to 79 years in the United Kingdom (UK).

13 Sep 2022

Study finds spike in the "Years of Life Lost" among adolescents during COVID-19 pandemic

The first year of the COVID-19 pandemic saw a 113% increase in the "Years of Life Lost" among adolescents and young people in the United States due to unintentional drug overdose, according to researchers at The Ohio State University Wexner Medical Center and College of Medicine.

13 Sep 2022

MIT researchers use new technique to gather insight into repetitive protein sequences

About 70 percent of all human proteins include at least one sequence consisting of a single amino acid repeated many times, with a few other amino acids sprinkled in. These "low-complexity regions" are also found in most other organisms.

13 Sep 2022

Study highlights role of tumor-infiltrating B cells, plasma cells in cancer development and treatment outcomes

Through extensive single-cell analysis, researchers at The University of Texas MD Anderson Cancer Center have created a spatial map of tumor-infiltrating B cells and plasma cells in early-stage lung cancers, highlighting previously unappreciated roles these immune cells play in tumor development and treatment outcomes.

13 Sep 2022

First-of-its-kind messenger RNA therapy developed for ovarian cancer, cachexia

Researchers at Oregon State University and Oregon Health & Science University have developed a promising, first-of-its-kind messenger RNA therapy for ovarian cancer as well as cachexia, a muscle-wasting condition associated with cancer and other chronic illnesses.

13 Sep 2022

New drug marks cancer cells for destruction by the immune system

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks.

13 Sep 2022

Cancer News and Research

Latest Cancer News and Research

Mechanical forces generated by T cells influence the destruction of cancer cells

Court ruling may spur competitive health plans to bring back copays for preventive services

AI used to identify pancreatic cancer in CT scans

Defensosomes versus COVID-19

Large molecules glom together into dense droplets to create squishy circuits in cells

Simple phone-based outreach strategy can help engage low-income smokers to try quitting tobacco

Microneedle technology for low-cost, painless, and bloodless tattoos

STRATAGEM aims to provide new perspectives on multidrug-resistant solid tumors

Scientists identify two distinct subtypes of obesity

California and New York aim to curb diet pill sales to minors

Study explores the impact of genetic risk variants on overall disease burden and healthy life years

Study estimates the cost-effectiveness of therapeutic alternatives

Signal transduction via the EGFR pathway likely to be involved in lenvatinib resistance

Risk of dementia reduced 50% by walking 9,800 steps a day

Every step counts to lower cancer and cardiovascular disease risk

Study finds spike in the "Years of Life Lost" among adolescents during COVID-19 pandemic

MIT researchers use new technique to gather insight into repetitive protein sequences

Study highlights role of tumor-infiltrating B cells, plasma cells in cancer development and treatment outcomes

First-of-its-kind messenger RNA therapy developed for ovarian cancer, cachexia

New drug marks cancer cells for destruction by the immune system

Understanding the DNA Damage Response in Innate Immunity eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in